The recommendation for cervical screening is that it should be based on human papillomavirus
(HPV) molecular testing. For all screening programs, attention to quality assurance is …

High risk human papillomavirus (HPV) has transformed head and neck oncology in the past
several decades. Now that we have recognized that HPV-positive oropharyngeal squamous …

… Results at recruitment from a randomized controlled trial comparing human papillomavirus
testing alone with conventional cytology as the primary cervical cancer screening test.  …

Background: Some countries have implemented stand-alone human papillomavirus (HPV)
testing while others consider cotesting for cervical cancer screening. We compared both …

Objectives Given the recent debate challenging the contribution of cytology in cervical
screening, we evaluated results of liquid-based cytology (LBC) and human papillomavirus (HPV) …

… high-risk human papillomavirus (HPV) testing than cytology … testing in middle-income
countries. Understanding the characteristics of HPV testing may increase the priority of HPV testing …

Background: Guidelines for cervical cancer screening have been updated to include human
papillomavirus (HPV) testing, which is more sensitive compared to cytology in detecting …

Objectives Cervical cancer is the second-most common type of cancer among women aged
15-44, and racial, ethnic, and economic disparities exist in survival rates despite widely …

With more than 200 types identified, human papillomavirus (HPV) commonly causes infections
of the skin and mucosa. HPV infection is the most common sexually transmitted infection …

Attendance at early recall and colposcopy is crucial to attaining the benefits of primary high‐risk
human papillomavirus (HR‐HPV)‐based screening. Within the English HPV pilot, we …